DK1037868T3 - Alfa-Hydroxy-, amino- og halogenderivater af beta-sulfonylhydroxamsyrer som matrixmetalloproteinaseinhibitorer - Google Patents

Alfa-Hydroxy-, amino- og halogenderivater af beta-sulfonylhydroxamsyrer som matrixmetalloproteinaseinhibitorer

Info

Publication number
DK1037868T3
DK1037868T3 DK98966869T DK98966869T DK1037868T3 DK 1037868 T3 DK1037868 T3 DK 1037868T3 DK 98966869 T DK98966869 T DK 98966869T DK 98966869 T DK98966869 T DK 98966869T DK 1037868 T3 DK1037868 T3 DK 1037868T3
Authority
DK
Denmark
Prior art keywords
unsubstituted
substituted
beta
alpha
hydroxy
Prior art date
Application number
DK98966869T
Other languages
Danish (da)
English (en)
Inventor
Martha A Warpehoski
Mark Allen Mitchell
Donald E Harper
Linda Louise Maggiora
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of DK1037868T3 publication Critical patent/DK1037868T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/46—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • C07C317/48—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C317/50—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyridine Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK98966869T 1997-11-21 1998-11-18 Alfa-Hydroxy-, amino- og halogenderivater af beta-sulfonylhydroxamsyrer som matrixmetalloproteinaseinhibitorer DK1037868T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7265597P 1997-11-21 1997-11-21
PCT/IB1998/002154 WO1999026909A2 (fr) 1997-11-21 1998-11-18 DERIVES α-HYDROXY, AMINO ET HALO D'ACIDES HYDROXAMIQUES β-SULFONYLE UTILISES COMME INHIBITEURS DE METALLOPROTEINASES MATRICIELLES

Publications (1)

Publication Number Publication Date
DK1037868T3 true DK1037868T3 (da) 2003-05-12

Family

ID=22108985

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98966869T DK1037868T3 (da) 1997-11-21 1998-11-18 Alfa-Hydroxy-, amino- og halogenderivater af beta-sulfonylhydroxamsyrer som matrixmetalloproteinaseinhibitorer

Country Status (24)

Country Link
US (2) US20030166687A1 (fr)
EP (1) EP1037868B1 (fr)
JP (1) JP2001524462A (fr)
KR (1) KR20010032319A (fr)
CN (1) CN1168709C (fr)
AT (1) ATE232192T1 (fr)
AU (1) AU763113B2 (fr)
BG (1) BG104346A (fr)
BR (1) BR9814699A (fr)
CA (1) CA2310401A1 (fr)
DE (1) DE69811273T2 (fr)
DK (1) DK1037868T3 (fr)
EA (1) EA003585B1 (fr)
ES (1) ES2192349T3 (fr)
HU (1) HUP0100812A3 (fr)
IL (1) IL135586A0 (fr)
IS (1) IS1954B (fr)
NO (1) NO20002505L (fr)
NZ (1) NZ503997A (fr)
PL (1) PL341153A1 (fr)
PT (1) PT1037868E (fr)
TR (1) TR200001391T2 (fr)
UA (1) UA66818C2 (fr)
WO (1) WO1999026909A2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU763113B2 (en) * 1997-11-21 2003-07-10 Pharmacia & Upjohn Company Alpha-hydroxy, -amino, and halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors
GB9927453D0 (en) * 1999-11-19 2000-01-19 Pharmacia & Upjohn Spa Crystalline and optically active form of a-hydroxy derivatives of ›-sulfonyl acid
DK1335898T3 (da) * 2000-09-29 2006-04-03 Topotarget Uk Ltd Carbaminsyreforbindelser omfattende en amidbinding som HDAC-inhibitorer
JP4975941B2 (ja) 2000-09-29 2012-07-11 トポターゲット ユーケー リミテッド （ｅ）−ｎ−ヒドロキシ−３−（３−スルファモイル−フェニル）アクリルアミド化合物及びその治療用途
JP2006516548A (ja) 2002-12-30 2006-07-06 アンジオテック インターナショナル アクツィエン ゲゼルシャフト 迅速ゲル化ポリマー組成物からの薬物送達法
DE10320453A1 (de) * 2003-05-08 2004-11-25 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Bioisostere von Actinonin
JP2009519349A (ja) * 2005-12-15 2009-05-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を変調する化合物
WO2008014199A2 (fr) * 2006-07-28 2008-01-31 Boehringer Ingelheim International Gmbh Composés modulant le récepteur cb2
KR20090069318A (ko) * 2006-09-25 2009-06-30 베링거 인겔하임 인터내셔날 게엠베하 Ｃｂ2 수용체를 조절하는 화합물
US7539361B2 (en) * 2006-10-05 2009-05-26 Harris Corporation Fiber optic device for measuring a parameter of interest
DE102006049618A1 (de) * 2006-10-20 2008-05-08 Tschesche, Harald, Prof. Dr. Triazine und Ihre Verwendung als Metalloproteinase-Inhibitoren
EP2217565B1 (fr) * 2007-11-07 2013-05-22 Boehringer Ingelheim International GmbH Composés modulant le récepteur cb2
JP5749162B2 (ja) * 2008-07-10 2015-07-15 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を調節するスルホン化合物
KR20110063438A (ko) * 2008-09-25 2011-06-10 베링거 인겔하임 인터내셔날 게엠베하 Ｃｂ2 수용체를 선택적으로 조절하는 설포닐 화합물
US8299103B2 (en) * 2009-06-15 2012-10-30 Boehringer Ingelheim International Gmbh Compounds which selectively modulate the CB2 receptor
WO2010147791A1 (fr) 2009-06-16 2010-12-23 Boehringer Ingelheim International Gmbh Dérivés d'azétidine 2-carboxamide qui modulent le récepteur cb2
JP2013505295A (ja) * 2009-09-22 2013-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃｂ２受容体を選択的に調節する化合物
EP2523936A1 (fr) 2010-01-15 2012-11-21 Boehringer Ingelheim International GmbH Composés qui modulent le récepteur cb2
WO2011109324A1 (fr) 2010-03-05 2011-09-09 Boehringer Ingelheim International Gmbh Composés tétrazoles qui modulent sélectivement le récepteur cb2
US8846936B2 (en) 2010-07-22 2014-09-30 Boehringer Ingelheim International Gmbh Sulfonyl compounds which modulate the CB2 receptor
EP2803668A1 (fr) 2013-05-17 2014-11-19 Boehringer Ingelheim International Gmbh Nouveau (cyano-dimethyl-methyl)-isoxazoles et - [1,3,4] thiadiazoles
US10221138B2 (en) * 2013-06-27 2019-03-05 Lg Chem, Ltd. Biaryl derivatives as GPR120 agonists
EP3717481B1 (fr) 2017-11-27 2023-03-01 Council of Scientific & Industrial Research Dérivés d'indole (sulfomyl) n-hydroxy benzamide en tant qu'inhibiteurs sélectifs de hdac

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0780386T3 (da) * 1995-12-20 2003-02-03 Hoffmann La Roche Matrixmetalloproteaseinhibitorer
DK0871439T3 (da) 1996-01-02 2004-08-02 Aventis Pharma Inc Substituerede (aryl, heteroaryl, arylmethyl eller heteroarylmethyl) hydroxamsyreforbindelser
WO1997049679A1 (fr) 1996-06-27 1997-12-31 Ono Pharmaceutical Co., Ltd. Derives d'aryle (sulfure, oxyde sulfonique et sulfone) et medicaments les contenant en tant que principe actif
CA2263154A1 (fr) 1996-08-07 1998-02-12 Darwin Discovery Limited Derives de l'acide hydroxamique et de l'acide carboxylique dotes d'une activite inhibitrice vis a vis des mmp et du tnf
ID21897A (id) * 1996-09-27 1999-08-05 Upjohn Co Asam b-sulfonil hidroksamat sebagai bahan penghambat matriks metaloproteinase
AU5337498A (en) * 1997-01-22 1998-08-18 Rhone-Poulenc Rorer Pharmaceuticals Inc. Substituted beta-thiocarboxylic acids
WO1998034915A1 (fr) 1997-02-07 1998-08-13 Pfizer Inc. Derives du n-hxdroxy-beta-sulfonyl-propionamide et leur utilisation comme inhibiteurs des metalloproteases matrices
WO1998039326A1 (fr) * 1997-03-04 1998-09-11 Monsanto Company Composes aromatiques d'acide sulfonyle alpha-hydroxy hydroxamique
IL131494A (en) * 1997-03-04 2005-06-19 Monsanto Co N-hydroxy 4-sulfonyl butanamide compounds and their use to prepare medicaments for treating conditions associated with matrix metalloproteinase activity
AU763113B2 (en) * 1997-11-21 2003-07-10 Pharmacia & Upjohn Company Alpha-hydroxy, -amino, and halo derivatives of beta-sulfonyl hydroxamic acids as matrix metalloproteinases inhibitors

Also Published As

Publication number Publication date
IS1954B (is) 2004-10-13
AU763113B2 (en) 2003-07-10
BR9814699A (pt) 2000-10-03
CA2310401A1 (fr) 1999-06-03
EA003585B1 (ru) 2003-06-26
EP1037868B1 (fr) 2003-02-05
IS5475A (is) 2000-04-28
IL135586A0 (en) 2001-05-20
PL341153A1 (en) 2001-03-26
PT1037868E (pt) 2003-06-30
BG104346A (en) 2001-01-31
NO20002505D0 (no) 2000-05-15
EA200000551A1 (ru) 2000-10-30
WO1999026909A3 (fr) 1999-08-26
US20030166687A1 (en) 2003-09-04
NZ503997A (en) 2001-09-28
HUP0100812A2 (hu) 2001-08-28
DE69811273D1 (de) 2003-03-13
WO1999026909A2 (fr) 1999-06-03
EP1037868A2 (fr) 2000-09-27
NO20002505L (no) 2000-06-30
KR20010032319A (ko) 2001-04-16
CN1168709C (zh) 2004-09-29
UA66818C2 (uk) 2004-06-15
ES2192349T3 (es) 2003-10-01
JP2001524462A (ja) 2001-12-04
TR200001391T2 (tr) 2000-11-21
AU2540599A (en) 1999-06-15
DE69811273T2 (de) 2003-12-11
HUP0100812A3 (en) 2002-11-28
US6437177B1 (en) 2002-08-20
ATE232192T1 (de) 2003-02-15
CN1278247A (zh) 2000-12-27

Similar Documents

Publication Publication Date Title
DK1037868T3 (da) Alfa-Hydroxy-, amino- og halogenderivater af beta-sulfonylhydroxamsyrer som matrixmetalloproteinaseinhibitorer
EA199900332A1 (ru) β-СУЛЬФОНИЛ ГИДРОКСАМОВЫЕ КИСЛОТЫ В КАЧЕСТВЕ ИНГИБИТОРОВ МАТРИЧНЫХ МЕТАЛЛОПРОТЕИНАЗ
AU4812697A (en) Alpha-amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors
AR014868A1 (es) UN COMPUESTO DERIVADO DE N,N ( SUSTITUIDO) FENIL (ARILO O HETEROARILO) PROPANAMINA, UNA COMPOSICIoN FARMACÉUTICA, USO DE DICHO COMPUESTO Y UN MÉTODO PARA PREPARARLO.
AR012603A1 (es) Inhibidor de proteasa, composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento; e intermediarios de sintesis
BR0002073A (pt) Processo para a preparação de um composto quiral
AR012092A1 (es) Compuestos derivados de aril y heteroaril carboxamida, procedimiento para su preparacion, composicion farmaceutica que lo comprenden, y el uso de dichosderivados para la fabricacion de un medicamento.
FI920435A (fi) N-(aryloxyalkyl) heteroaryl-8 -azabicyclo/3.2.1./oktaner, mellanprodukter och deras framstaellnings -foerfarande och deras anvaendning som laekemedel.
ATE277893T1 (de) N-(2-phenyl-4-amino-butyl)-1-naphthamide als neurokinin-1 rezeptorantagonisten
ES2191284T3 (es) Derivados de 2-fenoxianilina.
BR9812085A (pt) "método para a sìntese de derivados de quinolina"
AR044175A1 (es) Compuestos de cefemo
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
ATE293616T1 (de) 2-fluoro-(oxido-thiopyran-4-yl)benzol derivate
ES2165410T3 (es) Nuevas 5-(ariloxi-metil)-oxazolinas, su procedimiento de preparacion y las composiciones farmaceuticas que las contienen.
PT84161B (pt) Processo para a preparacao de derivados de 3-acilaminometil-imidazo-{1,2-a}-piridinas e de composicoes farmaceuticas que os contem
SV1998000088A (es) Compuestos farmaceuticos
DK1193260T3 (da) Phenoxazinanaloger til behandling af amyloidosis
SE9701438D0 (sv) A new process
AR017500A1 (es) Derivados de naftilpiperacin-ftalacinonas
TW200510350A (en) Sulfonamide derivatives having isoxazole ring
BR0113760A (pt) Novo cristal de n-hidróxi-2-(s)-metil-5-etoximetóxi-4 (s)-[n-(4fenóxifenilcarbonil) amino] pentamida e um processo para preparação como um agente farmacêutico compreendendo o mesmo como ingrediente ativo
ES2077985T3 (es) Inhibidores de la acil-coa: colesterol-acil transferasa, a base de 5-bis-aminometilen-1,3-dioxano-4,6-diona n,n',n'-trisubstituida.
UY27239A1 (es) Nuevos derivados de pirimidín-2,4,6-triona, procedimiento para su producción y agentes farmaceúticos que contienen estos compuestos.